Gene-Specific Intron Retention Serves As Molecular Signature That Distinguishes Melanoma from Non-Melanoma Cancer Cells in Greek Patients

Background: Skin cancer represents the most common human malignancy, and it includes BCC, SCC, and melanoma. Since melanoma is one of the most aggressive types of cancer, we have herein attempted to develop a gene-specific intron retention signature that can distinguish BCC and SCC from melanoma biopsy tumors.

Methods: Intron retention events were examined through RT-sqPCR protocols, using total RNA preparations derived from BCC, SCC, and melanoma Greek biopsy specimens. Intron-hosted miRNA species and their target transcripts were predicted via the miRbase and miRDB bioinformatics platforms, respectively. Ιntronic ORFs were recognized through the ORF Finder application. Generation and visualization of protein interactomes were achieved by the IntAct and Cytoscape softwares, while tertiary protein structures were produced by using the I-TASSER online server.

Results: and genes proved to undergo intron retention specifically in melanoma. Interaction maps of proteins encoded by genes being potentially targeted by retained intron-accommodated miRNAs were generated and was additionally delivered to our melanoma-specific signature. Novel ORFs were identified in and introns, with potentially critical roles in melanoma development.

Conclusions: The property of , , and genes to retain specific introns could be clinically used to molecularly differentiate non-melanoma from melanoma tumors.

Citing Articles

Identification of Intron Retention in the Slc16a3 Gene Transcript Encoding the Transporter MCT4 in the Brain of Aged and Alzheimer-Disease Model (APPswePS1dE9) Mice.

El-Seedy A, Pellerin L, Page G, Ladeveze V Genes (Basel). 2023; 14(10).

PMID: 37895298 PMC: 10606527. DOI: 10.3390/genes14101949.

Towards resolution of the intron retention paradox in breast cancer.

Shah J, Milevskiy M, Petrova V, Au A, Wong J, Visvader J Breast Cancer Res. 2022; 24(1):100.

PMID: 36581993 PMC: 9798573. DOI: 10.1186/s13058-022-01593-1.

Challenges in detecting and quantifying intron retention from next generation sequencing data.

Broseus L, Ritchie W Comput Struct Biotechnol J. 2020; 18:501-508.

PMID: 32206209 PMC: 7078297. DOI: 10.1016/j.csbj.2020.02.010.

miRNAs in the Diagnosis and Prognosis of Skin Cancer.

Neagu M, Constantin C, Cretoiu S, Zurac S Front Cell Dev Biol. 2020; 8:71.

PMID: 32185171 PMC: 7058916. DOI: 10.3389/fcell.2020.00071.

References

Owen D, Ornaghi P, Yang J, Lowe N, Evans P, Ballario P . The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p. EMBO J. 2000; 19(22):6141-9. PMC: 305837. DOI: 10.1093/emboj/19.22.6141. View

Kraehn G, Utikal J, Udart M, Greulich K, Bezold G, Kaskel P . Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases. Br J Cancer. 2001; 84(1):72-9. PMC: 2363612. DOI: 10.1054/bjoc.2000.1535. View

Holcik M, Korneluk R . XIAP, the guardian angel. Nat Rev Mol Cell Biol. 2001; 2(7):550-6. DOI: 10.1038/35080103. View

Zeng L, Zhou M . Bromodomain: an acetyl-lysine binding domain. FEBS Lett. 2002; 513(1):124-8. DOI: 10.1016/s0014-5793(01)03309-9. View

Dlugosz A, Merlino G, Yuspa S . Progress in cutaneous cancer research. J Investig Dermatol Symp Proc. 2003; 7(1):17-26. DOI: 10.1046/j.1523-1747.2002.19631.x. View

Dominguez C, Boelens R, Bonvin A . HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J Am Chem Soc. 2003; 125(7):1731-7. DOI: 10.1021/ja026939x. View

Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

Bowden G . Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling. Nat Rev Cancer. 2003; 4(1):23-35. DOI: 10.1038/nrc1253. View

Chawla-Sarkar M, Bae S, Reu F, Jacobs B, Lindner D, Borden E . Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ. 2004; 11(8):915-23. DOI: 10.1038/sj.cdd.4401416. View

10.

Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

11.

Rodriguez A, Griffiths-Jones S, Ashurst J, Bradley A . Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004; 14(10A):1902-10. PMC: 524413. DOI: 10.1101/gr.2722704. View

12.

Slominski A, Tobin D, Shibahara S, Wortsman J . Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev. 2004; 84(4):1155-228. DOI: 10.1152/physrev.00044.2003. View

13.

Patel S, Leal A, Gorski D . The homeobox gene Gax inhibits angiogenesis through inhibition of nuclear factor-kappaB-dependent endothelial cell gene expression. Cancer Res. 2005; 65(4):1414-24. DOI: 10.1158/0008-5472.CAN-04-3431. View

14.

Garraway L, Widlund H, Rubin M, Getz G, Berger A, Ramaswamy S . Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature. 2005; 436(7047):117-22. DOI: 10.1038/nature03664. View

15.

Staib F, Robles A, Varticovski L, Wang X, Zeeberg B, Sirotin M . The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress. Cancer Res. 2005; 65(22):10255-64. PMC: 1421332. DOI: 10.1158/0008-5472.CAN-05-1714. View

16.

Roll P, Rudolf G, Pereira S, Royer B, Scheffer I, Massacrier A . SRPX2 mutations in disorders of language cortex and cognition. Hum Mol Genet. 2006; 15(7):1195-207. DOI: 10.1093/hmg/ddl035. View

17.

Ikeda K, Kundu R, Ikeda S, Kobara M, Matsubara H, Quertermous T . Glia maturation factor-gamma is preferentially expressed in microvascular endothelial and inflammatory cells and modulates actin cytoskeleton reorganization. Circ Res. 2006; 99(4):424-33. DOI: 10.1161/01.RES.0000237662.23539.0b. View

18.

Neville J, Welch E, Leffell D . Management of nonmelanoma skin cancer in 2007. Nat Clin Pract Oncol. 2007; 4(8):462-9. DOI: 10.1038/ncponc0883. View

19.

Altieri D . Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer. 2007; 8(1):61-70. DOI: 10.1038/nrc2293. View

20.

Epstein E . Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer. 2008; 8(10):743-54. PMC: 4457317. DOI: 10.1038/nrc2503. View